Drug profile · INN
sulfamethizole
PROKLAR
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sulfamethizole (PROKLAR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN sulfamethizole
Brand PROKLAR
Route ORAL
Formulation TABLET
Frequently asked questions
What is sulfamethizole?
sulfamethizole (PROKLAR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sulfamethizole?
PROKLAR is a marketed brand name for sulfamethizole. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sulfamethizole?
sulfamethizole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.